you are here: Home News Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Q4 Results Highlights: Sun Pharma earning call -US contributes 31.4% of Sun Pharma revenues
Sun Pharma Q3 net profit rises 15% to Rs 2,903.4 crore, meets estimate; Rs 10.5 dividend declared
Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations
Sun Pharma Q4 results: Net profit rises 34% to Rs 2,654.5 crore, final dividend of Rs 5 announced
Small pharma cos curtailing investments in the US, says Jefferies
Sun Pharma Q3 net profit rises 5% to Rs 2,166 crore
Sun Pharma profit may decline 10% in Q3 on poor operating performance
India Inc throws up a mixed bag in Q2 amid global headwinds, local play stays strong
Sun Pharma’s specialty drugs bet is beginning to pay off
Sun Pharma consolidated net profit rises more than 8%, beats estimate
Q2 Preview | Sun Pharma consolidated net may drop 4% on high R&D costs
Sun Pharma Q1 Result | Consolidated profit rises 43% YoY to Rs 2,061 crore
Sun Pharma Q1 Results Preview | Profit may rise 16%; revenue likely to dip 13%
Pharma Q4 Preview | Despite strong domestic demand and modest US growth, cost pressure, lower prices to dent margins
Pharma Q3 Preview | Lukewarm growth expected as US market sales slowdown
Sun Pharma: Q2 Results Preview – Revenues to increase by ~10% and Adjusted PAT by ~8%% on a YOY basis
Sun Pharma's senior exec, wife settle insider trading case with Sebi
Sun Pharma to make unit distributor for local formulations biz
Sun to sell Ranbaxy's 2 divisions to Strides for Rs 165 cr
Daiichi Sankyo to offload stake in Sun Pharma
FDA aapproves generic version of cancer drug Doxil
Technical outlook for the fortnight: Nirmal Bang
Sun Pharma to sell some Merck diabetes drugs in India
Merck, Sun Pharma eyeing India marketing tie-up?

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Sun Pharmaceutical Industries Ltd

Q4 Results Highlights: Sun Pharma earning call -US contributes 31.4% of Sun Pharma revenues

Sun Pharma Q3 net profit rises 15% to Rs 2,903.4 crore, meets estimate; Rs 10.5 dividend declared

Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,654.5 crore, final dividend of Rs 5 announced

Small pharma cos curtailing investments in the US, says Jefferies

Sun Pharma Q3 net profit rises 5% to Rs 2,166 crore

Sun Pharma profit may decline 10% in Q3 on poor operating performance

India Inc throws up a mixed bag in Q2 amid global headwinds, local play stays strong

Sun Pharma’s specialty drugs bet is beginning to pay off

Sun Pharma consolidated net profit rises more than 8%, beats estimate

Q2 Preview | Sun Pharma consolidated net may drop 4% on high R&D costs

Sun Pharma Q1 Result | Consolidated profit rises 43% YoY to Rs 2,061 crore

Sun Pharma Q1 Results Preview | Profit may rise 16%; revenue likely to dip 13%

Pharma Q4 Preview | Despite strong domestic demand and modest US growth, cost pressure, lower prices to dent margins

Pharma Q3 Preview | Lukewarm growth expected as US market sales slowdown

Sun Pharma: Q2 Results Preview – Revenues to increase by ~10% and Adjusted PAT by ~8%% on a YOY basis

Sun Pharma's senior exec, wife settle insider trading case with Sebi

Sun Pharma to make unit distributor for local formulations biz

Sun to sell Ranbaxy's 2 divisions to Strides for Rs 165 cr

Daiichi Sankyo to offload stake in Sun Pharma

FDA aapproves generic version of cancer drug Doxil

Technical outlook for the fortnight: Nirmal Bang

Sun Pharma to sell some Merck diabetes drugs in India

Merck, Sun Pharma eyeing India marketing tie-up?